OLARATUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 22:13:12 GMT 2025` Edited by `admin` on `Mon Mar 31 22:13:12 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	TT6HN20MVF
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

olaratumab [INN]

Preferred Name

English

OLARATUMAB

Official Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR .ALPHA.) (HUMAN MONOCLONAL 3G3 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 3G3 .KAPPA.-CHAIN, DIMER

Common Name

English

IMC-3G3

Code

English

OLARATUMAB [MI]

Common Name

English

IMC3G3

Code

English

OLARATUMAB [PURPLE BOOK CDER]

Common Name

English

OLARATUMAB [JAN]

Common Name

English

LARTRUVO

Brand Name

English

Olaratumab [WHO-DD]

Common Name

English

OLARATUMAB [USAN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

FDA ORPHAN DRUG

448414

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

EU-Orphan Drug

EU/3/15/1447

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

NCI_THESAURUS

C129822

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

WHO-ATC

L01XC27

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

Code System Code Type Description

MERCK INDEX

m11962

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

FDA UNII

TT6HN20MVF

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

SMS_ID

100000134843

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

WIKIPEDIA

Olaratumab

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

LACTMED

Olaratumab

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

CAS

1024603-93-7

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

USAN

WW-104

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

EVMPD

SUB67904

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

INN

9308

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

RXCUI

1855735

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

ChEMBL

CHEMBL1743049

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

DRUG BANK

DB06043

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

NCI_THESAURUS

C79825

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

DRUG CENTRAL

5183

Created by admin on Mon Mar 31 22:13:12 GMT 2025 , Edited by admin on Mon Mar 31 22:13:12 GMT 2025

PRIMARY

From	To
1_22	1_97
1_154	1_210
1_230	3_214
1_236	2_236
1_239	2_239
1_271	1_331
1_377	1_435
2_22	2_97
2_154	2_210
2_230	4_214
2_271	2_331
2_377	2_435
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194

Related Record Type Details


					EXBA2DRFUB

PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					TT6HN20MVF

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC

Molecular Formula	CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Biological Half-life	PHARMACOKINETIC